Sponsor:
Cardioflow Technologies, LLC
Code:
NCT02984631
Conditions
Hypertension, Pulmonary
Heart Failure
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Preventing pulm HTN during exercise
Brief summary:
Conditions
Hypertension, Pulmonary
Heart Failure
Study ID
NCT02984631
Start date
Dec, 2016
Status verified date
Apr, 2018
Completion date
Jun, 2019
Anticipated
Primary completion date
Jun, 2019
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Non randomized
Intervention Model
Crossover
Primary purpose
Diagnostic
Arms
other: Preventing pulm HTN during exercise 2nd
other: Preventing pulm HTN during exercise 1st
Interventions
Preventing pulm HTN during exercise
Primary outcome measure
Central contacts
Daniel W Kaiser, MD
danielkaisermd@gmail.comLocations
El Camino Hospital
Recruiting
Mountain View, California, United States, 94040
Sponsor
Cardioflow Technologies, LLC
Last update posted
Apr 9, 2018
Last verified
Apr, 2018
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Cardioflow Technologies, LLC on 2018-04-09.